318
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Cosmetic Considerations in Dark-Skinned Patients

ORCID Icon, ORCID Icon & ORCID Icon
Pages 259-277 | Received 15 Nov 2023, Accepted 16 Jan 2024, Published online: 31 Jan 2024

References

  • Freeman RG, Cockerell EG, Armstrong J, Knox JM. Sunlight as a factor influencing the thickness of epidermis. J Invest Dermatol. 1962;39(4):295–298. doi:10.1038/jid.1962.115
  • Thomson ML. Relative efficiency of pigment and horny layer thickness in protecting the skin of Europeans and Africans against solar ultraviolet radiation. J Physiol. 1955;127(2):236–246. doi:10.1113/jphysiol.1955.sp005252
  • Weigand DA, Haygood C, Gaylor JR. Cell layers and density of Negro and Caucasian stratum corneum. J Invest Dermatol. 1974;62(6):563–568. doi:10.1111/1523-1747.ep12679412
  • Reed JT, Ghadially R, Elias PM. Effect of race, gender and skin type on epidermal permeability barrier function. J Invest Dermatol. 1994;102:537.
  • Reinertson RP, Wheatley VR. Studies on the chemical composition of human epidermal lipids. J Invest Dermatol. 1959;32(1):49–59. doi:10.1038/jid.1959.11
  • Sugino K, Imokawa G, Maibach HI. Ethnic difference of stratum corneum lipid in relation to stratum corneum function. J Invest Dermatol. 1993;100:597.
  • Wedig JH, Maibach HI. Percutaneous penetration of dipyrithione in man: effect of skin color (race). J Am Acad Dermatol. 1981;5(4):433–438. doi:10.1016/S0190-9622(81)70105-1
  • Berardesca E, Maibach HI. Racial differences in pharmacodynamic response to nicotinates in vivo in human skin: black and white. Acta Derm Venereol. 1990;70(1):63–66. doi:10.2340/00015555706366
  • Wickrema Sinha AJ, Shaw SR, Weber DJ. Percutaneous absorption and excretion of tritium-labeled diflorasone diacetate, a new topical corticosteroid in the rat, monkey and man. J Invest Dermatol. 1978;71(6):372–377. doi:10.1111/1523-1747.ep12556772
  • Berardesca E, de Rigal J, Leveque JL, Maibach HI. In vivo biophysical characterization of skin physiological differences in races. Dermatologica. 1991;182(2):89–93. doi:10.1159/000247752
  • Wilson D, Berardesca E, Maibach HI. In vitro transepidermal water loss: differences between black and white human skin. Br J Dermatol. 1988;119(5):647–652. doi:10.1111/j.1365-2133.1988.tb03478.x
  • Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol. 1970;101(5):580–584. doi:10.1001/archderm.1970.04000050084011
  • Kaidbey KH, Kligman AM. A human model of coal tar acne. Arch Dermatol. 1974;109(2):212–215. doi:10.1001/archderm.1974.01630020028006
  • Salam A, Dadzie OE, Galadari H. Chemical peeling in ethnic skin: an update. Br J Dermatol. 2013;169(Suppl 3):82–90. doi:10.1111/bjd.12535
  • Rullan P, Karam AM. Chemical peels for darker skin types. Facial Plast Surg Clin North Am. 2010;18(1):111–131. doi:10.1016/j.fsc.2009.11.010
  • Clark E, Scerri L. Superficial and medium-depth chemical peels. Clin Dermatol. 2008;26(2):209–218. doi:10.1016/j.clindermatol.2007.09.015
  • Sarkar R, Bansal S, Garg VK. Chemical peels for melasma in dark-skinned patients. J Cutan Aesthet Surg. 2012;5(4):247–253. doi:10.4103/0974-2077.104912
  • Vanaman M, Fabi SG, Carruthers J. Complications in the cosmetic dermatology patient: a review and our experience (Part 2). Dermatol Surg. 2016;42(1):12–20. doi:10.1097/01.DSS.0000479796.34703.94
  • Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23(3):171–174. doi:10.1111/j.1524-4725.1997.tb00014.x
  • Wang CM, Huang CL, Hu CTS, Chan HL. The effect of glycolic acid on the treatment of acne in asian skin. Dermatol Surg. 1997;23(1):23–29. doi:10.1111/j.1524-4725.1997.tb00003.x
  • Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg. 2002;28(9):828–832. doi:10.1046/j.1524-4725.2002.02034.x
  • Kalla G, Garg A, Kachhawa D. Chemical peeling--glycolic acid versus trichloroacetic acid in melasma. Indian J Dermatol Venereol Leprol. 2001;67(2):82–84.
  • Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76(4):447. doi:10.4103/0378-6323.66602
  • Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18–22. doi:10.1046/j.1524-4725.1999.08145.x
  • Bae BG, Park CO, Shin H, et al. Salicylic acid peels versus jessner’s solution for acne vulgaris: a comparative study. Dermatol Surg. 2013;39(2):248–253. doi:10.1111/dsu.12018
  • Dayal S, Amrani A, Sahu P, Jain VK. Jessner’s solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris. J Cosmet Dermatol. 2017;16(1):43–51. doi:10.1111/jocd.12266
  • Garg VK, Sarkar R, Agarwal R. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. Dermatol Surg. 2008;34(8):1032–1039. doi:10.1111/j.1524-4725.2008.34202.x
  • Shpall R, Beddingfield FC, Watson D, Lask GP. Microdermabrasion: a review. Facial Plast Surg. 2004;20(1):47–50. doi:10.1055/s-2004-822958
  • Karimipour DJ, Karimipour G, Orringer JS. Microdermabrasion: an evidence-based review. Plast Reconstr Surg. 2010;125(1):372–377. doi:10.1097/PRS.0b013e3181c2a583
  • Davis EC, Callender VD. Aesthetic dermatology for aging ethnic skin. Dermatol Surg. 2011;37(7):901–917. doi:10.1111/j.1524-4725.2011.02007.x
  • Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C. Different types of botulinum toxin in humans. Mov Disord. 2004;19(Suppl 8):S53–9. doi:10.1002/mds.20010
  • Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg. 2003;29(1):7–13; discussion. doi:10.1046/j.1524-4725.2003.29017.x
  • Flynn TC, Clark RE. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion. Dermatol Surg. 2003;29(5):519–522. doi:10.1046/j.1524-4725.2003.29124.x
  • Carruthers A, Carruthers J. Botulinum toxin. In: Bolognia JL, Jorrizo JL, Rapini RP, editors. Dermatology. New York: Elsevier Mosby; 2008:2381–2391.
  • Taylor SC, Grimes PE, Joseph JH, Jonker A, Avelar RL. PrabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines in adult patients with skin of color: post hoc analyses of the US Phase III clinical study data. Dermatol Surg. 2021;47(4):516–521. doi:10.1097/DSS.0000000000002864
  • Hexsel DM, Hexsel CL, Brunetto LT. Botulinum toxin. In: Grimes PE, Soriano T, Hexsel DM, Kim J, editors. Aesthetics and Cosmetic Surgery for Darker Skin Types. Philadelphia: Lippincott Williams & Wilkins; 2008:211–224.
  • Vashi NA, de Castro Maymone MB, Kundu RV. Aging differences in ethnic skin. J Clin Aesthet Dermatol. 2016;9(1):31–38.
  • Ahn J, Horn C, Blitzer A. Botulinum toxin for masseter reduction in Asian patients. Arch Facial Plast Surg. 2004;6(3):188–191. doi:10.1001/archfaci.6.3.188
  • Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003;29(5):477–483. doi:10.1046/j.1524-4725.2003.29116.x
  • Quiñonez RL, Agbai ON, Burgess CM, Taylor SC. An update on cosmetic procedures in people of color. Part 2: neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction. J Am Acad Dermatol. 2022;86(4):729–739. doi:10.1016/j.jaad.2021.07.080
  • Jiang H, Zhou J, Chen S. Different glabellar contraction patterns in Chinese and efficacy of botulinum toxin type a for treating glabellar lines: a pilot study. Dermatol Surg. 2017;43(5):692–697. doi:10.1097/DSS.0000000000001045
  • Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10(3):153–168. doi:10.2165/00128071-200910030-00002
  • Ahn KY, Park MY, Park DH, Han DG. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg. 2000;105(2):778–784. doi:10.1097/00006534-200002000-00050
  • Kane MA, Brandt F, Rohrich RJ, Narins RS, Monheit GD, Huber MB. Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a Phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg. 2009;124(5):1619–1629. doi:10.1097/PRS.0b013e3181b5641b
  • Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatol Surg. 2009;35(12):1893–1901. doi:10.1111/j.1524-4725.2009.01235.x
  • Brin MF, Boodhoo TI, Pogoda JM, et al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol. 2009;61(6):961–70. doi:10.1016/j.jaad.2009.06.040
  • Beddingfield F, Kim J. Fillers in ethnic skin. In: Grimes PE, Soriano T, Hexsel DM, Kim J, editors. Aesthetics and Cosmetic Surgery for Darker Skin Types. Philadelphia: Lippincott Williams & Wilkins; 2008:225–240.
  • Tierney E, Sengelmann RD, Sattler G, Hanke CW. Soft tissue augmentation. In: Robinson JK, Hanke CW, Siegel DM, Fratila A, editors. Surgery of the Skin. Philadelphia: Mosby Elsevier; 2010:363–391.
  • Harris MO. The aging face in patients of color: minimally invasive surgical facial rejuvenation-a targeted approach. Dermatol Ther. 2004;17(2):206–211. doi:10.1111/j.1396-0296.2004.04021.x
  • Burgess C, Awosika O. Ethnic and gender considerations in the use of facial injectables: African-American patients. Plastic Reconst Surg. 2015;136(5 Suppl):28s–31s. doi:10.1097/PRS.0000000000001813
  • Odunze M, Cohn A, Few JW. Restylane and people of color. Plast Reconstr Surg. 2007;120(7):2011–2016. doi:10.1097/01.prs.0000287330.94038.63
  • Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial. Dermatol Surg. 2009;35(Suppl 2):1653–1660. doi:10.1111/j.1524-4725.2009.01344.x
  • Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008;34(Suppl 1):S105–9. doi:10.1111/j.1524-4725.2008.34251.x
  • Marmur ES, Taylor SC, Grimes PE, Boyd CM, Porter JP, Yoo JY. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI. Dermatol Surg. 2009;35(Suppl 2):1641–1645. doi:10.1111/j.1524-4725.2009.01311.x
  • Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8(3):162–168. doi:10.1111/j.1473-2165.2009.00457.x
  • Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448–462. doi:10.1016/j.jaad.2009.07.040
  • Lin JY, Lin CY. Nonsurgical lower eyelid rejuvenation using injectable poly-d, l-lactic acid in Asian patients. J Cosmet Dermatol. 2022;21(10):4328–4331. doi:10.1111/jocd.15047
  • Shah S, Alster TS. Laser treatment of dark skin: an updated review. Am J Clin Dermatol. 2010;11(6):389–397. doi:10.2165/11538940-000000000-00000
  • Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002;46(2):S41–S62. doi:10.1067/mjd.2002.120790
  • Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014;23(1):49–60. doi:10.5978/islsm.14-RE-01
  • Chapas AM, Geronemus RG, Hale EK. Energy-based treatment of the aging face for skin resurfacing: ablative and non-ablative lasers, photodynamic therapy of photoaging, and actinic damage. In: Robinson JK, Hanke CW, Siegel DM, Fratila A, editors. Surgery of the Skin. Philadelphia: Mosby Elsevier; 2010:549–561.
  • Bhatt N, Alster TS. Laser surgery in dark skin. Dermatol Surg. 2008;34(2):184–194. doi:10.1111/j.1524-4725.2007.34036.x
  • Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg. 1998;24(3):315–320. doi:10.1111/j.1524-4725.1998.tb04161.x
  • West TB, Alster TS. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. Dermatol Surg. 1999;25(1):15–17. doi:10.1046/j.1524-4725.1999.08123.x
  • Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–438. doi:10.1002/lsm.20048
  • Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg. 2010;36(3):299–306. doi:10.1111/j.1524-4725.2009.01434.x
  • Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39(5):381–385. doi:10.1002/lsm.20512
  • Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008;34(3):301–305. doi:10.1111/j.1524-4725.2007.34062.x
  • Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R. Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol. 2010;63(2):274–283. doi:10.1016/j.jaad.2009.08.051
  • Vaiyavatjamai P, Wattanakrai P. Side effects and complications of fractional 1550-nm erbium fiber laser treatment among Asians. J Cosmet Dermatol. 2011;10(4):313–316. doi:10.1111/j.1473-2165.2011.00585.x
  • Mariwalla K, Hruza GJ. Laser treatment of pigmented lesions and tattoos. In: Hruza GJ, Avram M, editors. Lasers and Lights. New York: Saunders Elsevier; 2013:20–32.
  • Hofbauer Parra CA, Careta MF, Valente NY, de Sanches Osorio NE, Torezan LA. Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2016;42(4):507–512. doi:10.1097/DSS.0000000000000653
  • Wong Y, Lee SS, Goh CL. Hypopigmentation induced by frequent low-fluence, large-spot-size QS Nd:YAG laser treatments. Ann Dermatol. 2015;27(6):751–755. doi:10.5021/ad.2015.27.6.751
  • Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36(1):76–87. doi:10.1111/j.1524-4725.2009.01383.x
  • Sugawara J, Kou S, Kou S, Yasumura K, Satake T, Maegawa J. Influence of the frequency of laser toning for melasma on occurrence of leukoderma and its early detection by ultraviolet imaging. Lasers Surg Med. 2015;47(2):161–167. doi:10.1002/lsm.22325
  • Reiter O, Atzmony L, Akerman L, et al. Picosecond lasers for tattoo removal: a systematic review. Lasers Med Sci. 2016;31(7):1397–1405. doi:10.1007/s10103-016-2001-0
  • Ungaksornpairote C, Manuskiatti W, Junsuwan N, Wanitphakdeedecha R. A Prospective, split-face, randomized study comparing picosecond to Q-Switched Nd: YAG laser for treatment of epidermal and dermal pigmented lesions in Asians. Dermatol Surg. 2020;46(12):1671–1675. doi:10.1097/DSS.0000000000002486
  • Chan MWM, Shek SY, Yeung CK, Chan HH. A prospective study in the treatment of lentigines in asian skin using 532 nm picosecond Nd:YAG laser. Lasers Surg Med. 2019;51(9):767–773. doi:10.1002/lsm.23103
  • Vachiramon V, Iamsumang W, Triyangkulsri K. Q-switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians. Lasers Med Sci. 2018;33(9):1941–1947. doi:10.1007/s10103-018-2560-3
  • Kaewkes A, Manuskiatti W, Cembrano KA, Wanitphakdeedecha R. Treatment of abdominal striae distensae in Fitzpatrick skin types IV to V using a 1064-nm picosecond laser with a fractionated microlens array. Lasers Surg Med. 2022;54(1):129–137. doi:10.1002/lsm.23471
  • Fusano M, Galimberti MG, Bencini M, Guida S, Bencini PL. Picosecond laser treatment of striae distensae: in vivo evaluation of results by 3D analysis, reflectance confocal microscopy, and patient’s satisfaction. Lasers Surg Med. 2021;53(9):1180–1185. doi:10.1002/lsm.23401
  • Manuskiatti W, Punyaratabandhu P, Tantrapornpong P, Yan C, Cembrano KAG. Objective and Long-term evaluation of the efficacy and safety of a 1064-nm picosecond laser with fractionated microlens array for the treatment of atrophic acne scar in Asians. Lasers Surg Med. 2021;53(7):899–905. doi:10.1002/lsm.23368
  • Chayavichitsilp P, Limtong P, Triyangkulsri K, Pratumchart N. Comparison of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) 1064-nm picosecond laser and fractional 1550-nm erbium fiber laser in facial acne scar treatment. Lasers Med Sci. 2020;35(3):695–700. doi:10.1007/s10103-019-02891-5
  • Kwon HH, Yang SH, Cho YJ, et al. Comparison of a 1064-nm neodymium-doped yttrium aluminum garnet picosecond laser using a diffractive optical element vs. a nonablative 1550-nm erbium-glass laser for the treatment of facial acne scarring in Asian patients: a 17-week prospective, randomized, split-face, controlled trial. J Eur Acad Dermatol Venereol. 2020;34(12):2907–2913. doi:10.1111/jdv.16643
  • Huang CH, Chern E, Peng JH, Hsien-Li Peng P. Noninvasive atrophic acne scar treatment in Asians With a 755-nm Picosecond laser using a diffractive optic lens-A retrospective photographic review. Dermatol Surg. 2019;45(2):195–202. doi:10.1097/DSS.0000000000001669
  • Haimovic A, Brauer JA, Cindy Bae YS, Geronemus RG. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74(5):931–936. doi:10.1016/j.jaad.2015.12.010
  • Palawisuth S, Manuskiatti W, Apinuntham C, Wanitphakdeedecha R, Cembrano KAG. Quantitative assessment of the long-term efficacy and safety of a 1064-nm picosecond laser with fractionated microlens array in the treatment of enlarged pores in Asians: a case-control study. Lasers Surg Med. 2022;54(3):348–354. doi:10.1002/lsm.23449
  • Rubin IK, Kelly KM. Laser treatments of vascular lesions. In: Hruza GJ, Avram M, editors. Lasers and Lights. New York: Saunders Elsevier; 2013:10–19.
  • Vejjabhinanta V, Nouri K, Singh A, Huo R, Charoenwad R. Laser for hair removal. In: Nouri K, editor. Lasers in Dermatology and Medicine. New York: Springer; 2012:91–101.
  • Lanigan SW. Incidence of side effects after laser hair removal. J Am Acad Dermatol. 2003;49(5):882–886. doi:10.1016/S0190-9622(03)02106-6
  • Eremia S, Li CY, Umar SH, Newman N. Laser hair removal: long-term results with a 755 nm alexandrite laser. Dermatol Surg. 2001;27(11):920–924. doi:10.1046/j.1524-4725.2001.01074.x
  • Nanni CA, Alster TS. Long-pulsed alexandrite laser-assisted hair removal at 5, 10, and 20 millisecond pulse durations. Lasers Surg Med. 1999;24(5):332–337. doi:10.1002/(SICI)1096-9101(1999)24:5<332::AID-LSM3>3.0.CO;2-2
  • Nanni CA, Alster TS. Laser-assisted hair removal: side effects of Q-switched Nd:YAG, long-pulsed ruby, and alexandrite lasers. J Am Acad Dermatol. 1999;41(2 Pt 1):165–171. doi:10.1016/S0190-9622(99)70043-5
  • Vachiramon V, McMichael AJ. Patient knowledge and attitudes on laser hair removal: a survey in people of color. J Cosmet Dermatol. 2011;10(3):197–201. doi:10.1111/j.1473-2165.2011.00567.x
  • Greppi I. Diode laser hair removal of the black patient. Lasers Surg Med. 2001;28(2):150–155. doi:10.1002/lsm.1031
  • Atta-Motte M, Załęska I. Diode laser 805 hair removal side effects in groups of various ethnicities - cohort study results. J Lasers Med Sci. 2020;11(2):132–137. doi:10.34172/jlms.2020.23
  • Rapp KK, Steiner R. Intense pulse light technology. In: Raulin C, Karsai S, editors. Laser and IPL Technology in Dermatology and Aesthetic Medicine. Berlin: Springer-Verlag Berlin Heidelberg; 2011:37–40.
  • Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32(2):78–87. doi:10.1002/lsm.10145
  • Bogle MA, Kaminer MS. Non-surgical skin tightening. In: Hruza GJ, Avram M, editors. Lasers and Lights. New York: Saunders Elsevier; 2013:97–113.
  • Chua SH, Ang P, Khoo LS, Goh CL. Nonablative infrared skin tightening in Type IV to V Asian skin: a prospective clinical study. Dermatol Surg. 2007;33(2):146–151. doi:10.1111/j.1524-4725.2006.33032.x
  • Beasley KL, Weiss RA. Radiofrequency in cosmetic dermatology. Dermatol Clin. 2014;32(1):79–90. doi:10.1016/j.det.2013.09.010
  • Kushikata N, Negishi K, Tezuka Y, Takeuchi K, Wakamatsu S. Non-ablative skin tightening with radiofrequency in Asian skin. Lasers Surg Med. 2005;36(2):92–97. doi:10.1002/lsm.20136
  • Minkis K, Alam M. Ultrasound skin tightening. Dermatol Clin. 2014;32(1):71–77. doi:10.1016/j.det.2013.09.001
  • Fabi SG. Microfocused ultrasound with visualization for skin tightening and lifting: my experience and a review of the literature. Dermatol Surg. 2014;40(Suppl 12):S164–7. doi:10.1097/DSS.0000000000000233
  • Harris MO, Sundaram HA. Safety of microfocused ultrasound with visualization in patients with Fitzpatrick skin phototypes III to VI. JAMA Facial Plast Surg. 2015;17(5):355–357. doi:10.1001/jamafacial.2015.0990
  • Swami V, Furnham A, Joshi K. The influence of skin tone, hair length, and hair colour on ratings of women’s physical attractiveness, health and fertility. Scand J Psychol. 2008;49(5):429–437. doi:10.1111/j.1467-9450.2008.00651.x
  • Dlova NC, Hamed SH, Tsoka-Gwegweni J, Grobler A. Skin lightening practices: an epidemiological study of South African women of African and Indian ancestries. Br J Dermatol. 2015;173(uppl 2):2–9. doi:10.1111/bjd.13556
  • Martin JM, Ghaferi JM, Cummins DL, et al. Changes in skin tanning attitudes. Fashion articles and advertisements in the early 20th century. Am J Public Health. 2009;99(12):2140–2146. doi:10.2105/AJPH.2008.144352